NCT01483664Active, not recruiting
Communication Skills Intervention to Promote Transition Into Survivorship
Source: ClinicalTrials.gov · Last updated 20 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 314 (actual)
- First submitted
- 29 Nov 2011
- Start date
- Nov 2011
- Primary completion date
- Nov 2026
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- NCT number
- NCT01483664
What you commit to
- Study type: Observational
- Participants enrolled: 314
- From Nov 2011 to the primary completion date, Nov 2026
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.
Other
- Physicians:
- who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report
- Patients of Physicians:
- as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.
- For Part 2 ONLY (longitudinal phase):
- those who consented to part 1, consult recording, of the study.
Who the study is looking for
- Physicians:
- who treat patients with DLBCL and HD as per self report
- Patients of Physicians:
- have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.
- For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
- For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.
- be at least 18 years old
- speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge Coordinator of this site? Confirm its status | Basking Ridge | United States | Unknown status |
| Maimonides Medical Center Coordinator of this site? Confirm its status | Brooklyn | United States | Unknown status |
| Memorial Sloan Kettering Cancer Center at Commack Coordinator of this site? Confirm its status | Commack | United States | Unknown status |
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Memorial Sloan Kettering Cancer Center at Mercy Coordinator of this site? Confirm its status | Rockville Centre | United States | Unknown status |
| Memorial Sloan Kettering Cancer Center at Phelps Coordinator of this site? Confirm its status | Sleepy Hollow | United States | Unknown status |
| Tampa General Hospital Coordinator of this site? Confirm its status | Tampa | United States | Unknown status |
| Moffitt Cancer Center Coordinator of this site? Confirm its status | Tampa | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.